Newbridge Financial Services Group, Inc. Vericel Corp Transaction History

Newbridge Financial Services Group, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 21, 2023	SELL	$29.0 - $38.37 $8,700 - $11,511	-300 Reduced 99.34%	2 $0
Q1 2023 Apr 18, 2023	SELL	$23.85 - $31.34 $23,850 - $31,340	-1,000 Reduced 76.8%	302 $8,000
Q4 2022 Jan 17, 2023	SELL	$17.65 - $27.37 $12,354 - $19,159	-700 Reduced 34.97%	1,302 $0
Q3 2022 Oct 13, 2022	BUY	$22.62 - $32.54 $45,240 - $65,080	2,000 Added 100000.0%	2,002 $46,000
Q2 2022 Jul 15, 2022	BUY	$22.88 - $39.45 $45 - $78	2 New	2 $0

293

50.7M

98.2K

135K

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.18B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

Get notified when there are updates to the investment portfolio of Newbridge Financial Services Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Newbridge Financial Services Group, Inc. with notifications on news.